Inspiremd Stock Investor Sentiment

NSPR Stock  USD 2.76  0.18  6.12%   
Slightly above 61% of InspireMD's investor base is looking to short. The analysis of overall sentiment of trading InspireMD stock suggests that many investors are alarmed at this time. InspireMD's investing sentiment overview a quick insight into current market opportunities from investing in InspireMD. Many technical investors use InspireMD stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  

InspireMD Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards InspireMD can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over a year ago at news.google.com         
InspireMD Announces Appointment of Medical Technology Executive Pete Ligotti as Executive Vice Presi...
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
20,000 Shares in InspireMD, Inc. Purchased by Avestar Capital LLC
news
over a year ago at thelincolnianonline.com         
StockNews.com Begins Coverage on InspireMD
news
over a year ago at news.google.com         
Where Will InspireMD Inc Stock Go Next After It Is Higher By 16.51 percent in a Week - InvestorsObse...
Google News at Macroaxis
over a year ago at globenewswire.com         
InspireMD Announces Issuance of Key U.S. Patent Covering Its SwitchGuard Neuroprotection System
Macroaxis News: globenewswire.com
over a year ago at benzinga.com         
InspireMD Announces Issuance of Key U.S. Patent Covering Its SwitchGuard Neuroprotection System
benzinga news
over a year ago at finance.yahoo.com         
InspireMD Announces Issuance of Key U.S. Patent Covering Its SwitchGuard Neuroprotection System
Yahoo News
over a year ago at news.google.com         
Is InspireMD Inc Stock a Good Value Friday - InvestorsObserver
Google News at Macroaxis
over a year ago at simplywall.st         
Gary Roubin Spends US127k Buying InspireMD Shares
Simply Wall St News at Macroaxis
over a year ago at finance.yahoo.com         
InspireMDs Gary Roubin Acquires 13 percent More Stock
Yahoo News
over a year ago at thelincolnianonline.com         
Gary S. Roubin Buys 50,000 Shares of InspireMD, Inc. Stock
news
over a year ago at news.google.com         
Should You Sell InspireMD Inc in Medical Devices Industry - InvestorsObserver
Google News at Macroaxis
over a year ago at seekingalpha.com         
InspireMD says Roubin buys 50K shares in co
seekingalpha News
over a year ago at news.google.com         
InspireMD Announces Strategic Agreement with Jacobs Institute to Execute Early Feasibility Study of ...
Google News at Macroaxis
over a year ago at finance.yahoo.com         
InspireMD Announces Strategic Agreement with Jacobs Institute to Execute Early Feasibility Study of ...
Yahoo News
Far too much social signal, news, headlines, and media speculation about InspireMD that are available to investors today. That information is available publicly through InspireMD media outlets and privately through word of mouth or via InspireMD internal channels. However, regardless of the origin, that massive amount of InspireMD data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of InspireMD news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of InspireMD relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to InspireMD's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive InspireMD alpha.

InspireMD Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Earnings call InspireMD reports growth and preps for U.S. CGuard launch
11/13/2024
2
InspireMD Third Quarter 2024 Earnings US0.16 loss per share
11/15/2024
3
InspireMD Appoints Scott R. Ward to Board of Directors
11/26/2024
4
InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard ...
12/09/2024
5
NSPR Stock May Gain as First Patient Enrolls in CGUARDIANS II Study - Nasdaq
12/11/2024
6
InspireMD, Inc. CFO Craig Shore to Retire, Company Initiates Search for SuccessorDecember 12, 2024-
12/12/2024
7
Acquisition by Roubin Gary S of 30625 shares of InspireMD at 1.3827 subject to Rule 16b-3
12/27/2024
8
Acquisition by Craig Shore of 106218 shares of InspireMD at 2.71 subject to Rule 16b-3
01/07/2025
9
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635
01/21/2025

Additional Tools for InspireMD Stock Analysis

When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.